Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18)

Human Papillomavirus Quadrivalent is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine:

  • Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16 and 18.
  • Genital warts (condyloma acuminata) caused by HPV types 6 and 11.

And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, and 18:

  • Cervical intraepithelial neoplasia (CIN) grade 2/3 and Cervical adenocarcinoma in situ (AIS).
  • Cervical intraepithelial neoplasia (CIN) grade 1.
  • Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3.
  • Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3.
  • Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3.

There are no products to list in this category.